NDC 43393-001

Mifepristone

Mifepristone

Mifepristone is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Genbiopro, Inc.. The primary component is Mifepristone.

Product ID43393-001_a70938c4-34a6-0dfc-e053-2a95a90a2fe3
NDC43393-001
Product TypeHuman Prescription Drug
Proprietary NameMifepristone
Generic NameMifepristone
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2019-05-01
Marketing CategoryANDA / ANDA
Application NumberANDA091178
Labeler NameGenBioPro, Inc.
Substance NameMIFEPRISTONE
Active Ingredient Strength200 mg/1
Pharm ClassesProgestational Hormone Receptor Antagonists [MoA],Progestin Antagonist [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 43393-001-06

6 CARTON in 1 PACKAGE (43393-001-06) > 1 BLISTER PACK in 1 CARTON > 1 TABLET in 1 BLISTER PACK (43393-001-01)
Marketing Start Date2019-05-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 43393-001-06 [43393000106]

Mifepristone TABLET
Marketing CategoryANDA
Application NumberANDA091178
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-05-01

NDC 43393-001-01 [43393000101]

Mifepristone TABLET
Marketing CategoryANDA
Application NumberANDA091178
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-05-01

Drug Details

Active Ingredients

IngredientStrength
MIFEPRISTONE200 mg/1

Pharmacological Class

  • Progestational Hormone Receptor Antagonists [MoA]
  • Progestin Antagonist [EPC]
  • Progestational Hormone Receptor Antagonists [MoA]
  • Progestin Antagonist [EPC]

NDC Crossover Matching brand name "Mifepristone" or generic name "Mifepristone"

NDCBrand NameGeneric Name
43393-001MifepristoneMIFEPRISTONE
83114-001MIFEPRISTONEmifepristone
76346-073KorlymMifepristone

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.